𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Induction of remission following a single dose of rituximab alone in a patient with minimal change nephrotic syndrome

✍ Scribed by Nobuyuki Amemiya; Takashi Takei; Chiari Kojima; Hirohiko Nokiba; Mitsuyo Itabashi; Kosaku Nitta

Publisher
Springer
Year
2011
Tongue
English
Weight
280 KB
Volume
15
Category
Article
ISSN
1342-1751

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Minimal change disease as the etiology o
Minimal change disease as the etiology of the nephrotic syndrome in a patient with angioimmunoblastic lymphadenopathy
✍ Staszewski, Harry ;Kumar, Ganesh ;Mishriki, Yousri πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 542 KB

Glomerular lesions have rarely been reported with angioimmunoblastic lymphadenopathy (AILD). A patient with histologically documented AILD developed the nephrotic syndrome. Renal biopsy demonstrated minimal change disease. Both the lymphadenopathy and the nephrotic syndrome spontaneously remitted in

Induction of complete remission in a pat
Induction of complete remission in a patient with acute myeloid leukemia refractory to high-dose chemotherapy through treatment with 5-azacytidine
✍ A. Kuendgen; T. GrΓ€f; F. Zohren; B. Hildebrandt; A. HΓΌnerlitΓΌrkoglu; N. Gatterma πŸ“‚ Article πŸ“… 2007 πŸ› Elsevier Science 🌐 English βš– 654 KB

For patients with acute myeloid leukemia refractory to intensive chemotherapy prognosis is very poor and treatment options are limited. 5-Azacytidine, a demethylating drug, is effective in the treatment of myelodysplastic syndromes when administered at a low-dose, subcutaneously. We report a case of